Drug Information Association Logo
Corporate Tagline

Postmarketing Drug Safety and Pharmacovigilance

Oct 21 2013 8:00AM - Oct 22 2013 4:45PM | DIA 800 Enterprise Rd Ste 200, Horsham, PA 19044-3509 USA

« Back to Listing


Learn the key tools available for pharmacovigilance, discuss their uses, and consider the future directions of the field. Gain knowledge of latest changes in the US and EU regulations and best practices will be discussed. 

You will gain a detailed understanding of the requirements and procedures that must be performed in order to remain in full compliance with legal obligations.

What You Will Learn 

  • How to make your pharmacovigilance program more efficient and compliant
  • US, European, and other global requirements and standards in drug safety and pharmacovigilance
  • Privacy, information technology, and data protection issues involved in drug safety
  • How to speak the language of drug safety, signaling, risk management and pharmacovigilance
  • Future of drug safety and pharmacovigilance
  • The basics of drug safety inspection

Who Should Attend 

Professionals who work in:

  • Global drug safety, pharmacovigilance, and risk management
  • Regulatory and legal affairs
  • CROs, start-ups, small companies, generic drug companies and anyone needing to get up to speed rapidly on the basics of drug safety and pharmacovigilance
  • Training and teaching of drug safety and pharmacovigilance
  • Clinical health care
  • New drug development
  • Outsourcing and offshoring of drug safety
  • Supervising and dealing with drug safety

Learning Objectives 

At the conclusion of this activity, participants should be able to:

  • Identify the legal and regulatory basis of postmarketing drug safety and pharmacovigilance
  • Describe how your drug safety system will perform on an audit or governmental inspection
  • Explain the requirements, changes, pitfalls and risks of drug safety and pharmacovigilance, and apply the knowledge gained in your daily pharmacovigilance functions
  • Describe your company’s drug safety system and determine whether it is meeting regulatory compliance needs and requirements

Special Offers 

Group Discounts Available! Register 3 and Get the 4th FREE!

Hotel & Travel 

Training Course Location
DIA Worldwide Headquarters
800 Enterprise Road, Suite 101
Horsham, PA 19044

Hotel Information
Homewood Suites
2650 Kelly Road
Warrington, PA 18976
Phone +1-215-343-1300
Fax +215-343-1335

A limited number of rooms are available at the reduced rate shown below (DIA is guaranteed until October 6, 2013, or until room block is filled). Attendees should make airline and room reservations as soon as possible.
When making reservations, mention the DIA training course.
Standard Room Rate
Click here for more hotel information

Contact Information 

Registration Questions
Elizabeth Espich, Customer Service Associate
Phone +
Fax +1-215.442.6199

Agenda and Event Logistics
Colleen Buckley, Event Planner
Phone +1.215.442.6108
Fax +1.215.442.6199


Previous Next

Continuing Education 

The Drug Information Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is designated for up to 15 contact hours or 1.5 continuing education units (CEU’s). Type of Activity: Knowledge

Pharmacy Credit Allocation:
Day 1: 7.5 contact hours or .75 CEUs; 0286-0000-13-045-L04-P
Day 2: 7.5 contact hours or .75 CEUs; 0286-0000-13-046-L04-P


DIA is required by the Accreditation Council for Pharmacy Education (ACPE) to report pharmacy-requested CEUs through the CPE Monitor system. All ACPE-certified activity credit requests need to be submitted through DIA’s My Transcript within 45-days post activity. Pharmacists will need to provide their National Association of Boards of Pharmacy (NABP) e-Profile ID and date of birth (MMDD) to ensure the data is submitted to the ACPE and NABP properly. If you need to obtain your NABP e-Profile, please visit www.cpemonitor.net.

Drug Information Association has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102 (703) 506-3275.

As an IACET Authorized Provider, Drug Information Association offers CEUs for its programs that qualify under the ANSI/IACET Standard. Drug Information Association is authorized by IACET to offer 1.5 CEUs for this program. Participants must attend the entire program in order to be able to receive an IACET statement of credit. No partial credit will be awarded.

This program is part of DIA’s Certificate Program and is awarded the following.
• Clinical Safety Certificate Program: 8 Core Units

For more information go to www.diahome.org/certificateprograms

Name Credit Type Max Credits CEU
Postmarketing Drug Safety and Pharmacovigilance ACPE 15.00 1.500
Postmarketing Drug Safety and Pharmacovigilance IACET 15.00 1.500

Disclosure Policy:

It is DIA policy that anyone in a position to control the content of a continuing education activity must disclose to the program audience (1) any real or apparent conflict(s) of interest related to the content of their presentation and/or the educational activity, and (2) discussions of unlabeled or unapproved uses of drugs or medical devices. Disclosure statements will be included in the course materials.

Statement of Credit:

If you would like to receive a statement of credit, you must attend the course, sign-in at the DIA registration desk each day of the course, and complete the on-line credit request process through My Transcript at www.diahome.org. Participants will be able to download a statement of credit upon successful submission of the credit request. My Transcript will be available for credit requests two weeks after the last day of the course.

To view DIA’s Grievance Policy, please visit the CE page on the DIA website at www.diahome.org/CE

Registration Fees 


Charitable Nonprofit/Academia Member
Member Government
Member Standard


Charitable Nonprofit/Academia Nonmember
NonMember Government
NonMember Standard
Group Discounts

Register 3 individuals from the same company and receive complimentary registration for a 4th! All 4 individuals must register and prepay at the same time – no exceptions. DIA will apply the value of the lowest applicable fee to this complimentary registration; it does NOT include fees for optional events or DIA membership. You may substitute group participants of the same membership status at any time; however, administrative fees may be incurred. Group registration is not available online and does not apply to the already discounted fees for government or charitable nonprofit/academia.

To take advantage of this offer, please make a copy of this registration form for EACH of the four registrants from your company. Include the names of all four group registrants on each of the forms and return them together to DIA.

Register Online

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

« Back to Listing Back To Top